Heidelberg, January 28, 2026 – RHEACELL GmbH & Co. KG is further expanding its presence in Heidelberg and already moved into a second site in the Pfaffengrund district in August of last year. At the start of the year, the site is now becoming visible to the outside world: This week, the company logo will be prominently installed and illuminated on the building – a sign of growth, innovative strength, and long-term commitment to the Heidelberg location.
The new site complements the company’s existing headquarters in the Heidelberg Technology Park and aligns with RHEACELL’s long-term strategic focus on science, research, and biomedical innovation. Thanks to its prominent location, the company will be clearly visible from the A5 motorway and from the Pfaffengrund industrial and commercial area.
“What is now becoming visible externally is the result of years of work by our team. The new site is another step in advancing our development and making therapies available in the long term for patients with high unmet medical needs.”
Dr. med. Christoph Ganss, CEO and Founder of RHEACELL
With the site expansion, RHEACELL is sending a strong signal for further growth: the company is systematically expanding its structures and creating attractive, future-oriented jobs in various fields. At the same time, RHEACELL is positioning itself as an attractive employer for specialists from Heidelberg’s innovation and research ecosystem.
PRESS CONTACT RHEACELL:
Daniela Weis
Im Neuenheimer Feld 517
69120 Heidelberg
T +49 6221 71833-22
E daniela.weis@rheacell.com
About RHEACELL
RHEACELL is a leading integrative biopharmaceutical stem cell company headquartered in Heidelberg. The company develops innovative cell therapies for patients with severe immune- and inflammation-related diseases for which there are currently only limited treatment options. The therapies are based on a unique mechanism of action that aims at the targeted control of inflammatory processes.
